✦ LIBER ✦

Pertuzumab has clinical activity in advanced ovarian cancer

Book ID: 120849868
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615510-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pertuzumab active in advanced cancer

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Clinical Activity of Gemcitabine Plus Pe

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

✍ Makhija, S.; Amler, L. C.; Glenn, D.; Ueland, F. R.; Gold, M. A.; Dizon, D. S.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 729 KB

Clinical Activity of Pertuzumab (rhuMAb

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

✍ Gordon, M. S.; Matei, D.; Aghajanian, C.; Matulonis, U. A.; Brewer, M.; Fleming, 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 351 KB

Pertuzumab may add benefit to gemcitabin

Pertuzumab may add benefit to gemcitabine in epithelial ovarian cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

A controlled clinical trial in advanced

A controlled clinical trial in advanced ovarian cancer

✍ M. Adams; K.A. Johansen; K.W. James; I. Rocker 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Estrone sulfatase activity in patients w

Estrone sulfatase activity in patients with advanced ovarian cancer

✍ Justin C. Chura; Charles H. Blomquist; Hyung S. Ryu; Peter A. Argenta 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 278 KB